article_metadata: Wen Dong Anli Dai Zhijun Wu Jiangtao Wang Tao Wu Yangfeng Du Wei Tian Jiang Zheng Yan Zhang Hongming Wang Juan Cai Susu Dong Yan Zhou Siyan Li Zemin Xiao
article_metadata: 10.3389/fimmu.2024.1371379
article_metadata: Front Immunol
article_metadata: 2024 May 31:15:1371379.
article_metadata: anti-pd-1 antibody smarca4-dut chemotherapy immune therapy tislelizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38881888/
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use DNA Helicases / deficiency DNA Helicases / genetics Transcription Factors / genetics
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use DNA Helicases / deficiency DNA Helicases / genetics Transcription Factors / genetics Case Reports Cisplatin / administration & dosage Cisplatin / therapeutic use Etoposide / administration & dosage Etoposide / therapeutic use Female Humans Male Nuclear Proteins / deficiency Nuclear Proteins / genetics Treatment Outcome Antibodies, Monoclonal, Humanized SMARCA4 protein, human DNA Helicases tislelizumab Transcription Factors Nuclear Proteins Etoposide Cisplatin
article_metadata: PMC11176515
article_metadata: 38881888
article_metadata: Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
article_metadata: 2024